01 1Corden Pharma Bergamo S.p.A.
01 1Opipramol Dihydrochloride
01 1Italy
NDC Package Code : 49964-0040
Start Marketing Date : 2009-11-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Opipramol Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Opipramol Dihydrochloride, including repackagers and relabelers. The FDA regulates Opipramol Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Opipramol Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Opipramol Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Opipramol Dihydrochloride supplier is an individual or a company that provides Opipramol Dihydrochloride active pharmaceutical ingredient (API) or Opipramol Dihydrochloride finished formulations upon request. The Opipramol Dihydrochloride suppliers may include Opipramol Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Opipramol Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Opipramol Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Opipramol Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Opipramol Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Opipramol Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Opipramol Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Opipramol Dihydrochloride suppliers with NDC on PharmaCompass.
We have 1 companies offering Opipramol Dihydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
